Introduction
Herpesvirus saimiri (HVS; Saimiriine herpesvirus type 2) is a T-lymphotropic member of the rhadinoviruses or g 2 -herpesviruses and persistently infects South American squirrel monkeys (Saimiri sciureus) as natural hosts, without signs of disease. In contrast, other New World monkey species develop malignant T-cell lymphoma after experimental infection with this virus (reviewed by Fickenscher and Fleckenstein, 2001 ). Subgroup C strains of HVS, especially the strain C488, transform human T lymphocytes to stable growth in culture. T cells with ab or gd T-cell receptors, with CD4 or CD8, and T-helper cells of type 1 (T H 1) or 2 (T H 2) can be transformed (Biesinger et al., 1992; De Carli et al., 1993; Yasukawa et al., 1995; Schrum et al., 1996; Fickenscher et al., 1997; Mackewicz et al., 1997; Fickenscher and Fleckenstein, 2002) . The growth-transformed human T cells harbor multiple copies of the viral genome as nonintegrated episomes without producing virus particles (Biesinger et al., 1992) . Furthermore, the transformed cells retain many essential features of normal T cells, such as surface phenotype, early signal transduction parameters, interleukin-2 (IL-2) dependence, major histocompatibility complex-restricted antigen specificity, inducible cytotoxicity, and cytokine production (Biesinger et al., 1992; Bro¨ker et al., 1993; De Carli et al., 1993; Mittru¨cker et al., 1993) .
Little is known about cellular features that are changed after transformation. The most pronounced phenotypic difference is a CD2-mediated enhanced proliferation of transformed T cells due to stimulation via cell-bound CD58, which is mediated by autocrine IL-2 and IL-3 production (Mittru¨cker et al., 1992; Del Prete et al., 1994) . Moreover, unusually high levels of interferon-g (IFN-g) are produced after stimulation, and a shift of transformed cells toward the T H 1 phenotype is observed (Bro¨ker et al., 1993; De Carli et al., 1993) . Similar to T cells transformed by human T-cell leukemia virus type 1 (HTLV1), the nonreceptor tyrosine kinase Lyn is aberrantly expressed and enzymatically active in T cells after HVS transformation (Yamanashi et al., 1989; Wiese et al., 1996; Fickenscher et al., 1997) . Functional consequences of this phenomenon have not yet been defined. By suppressive subtractive hybridization (SSH), we were able to isolate a novel cellular gene coding for IL-26/AK155, which is specifically overexpressed in HVS-transformed T cells and belongs to the IL-10 family of cytokines (Knappe et al., 2000; .
Only two viral genes were shown to be constitutively expressed in HVS-transformed human T lymphocytes: these genes code for the HVS transformation-associated protein of subgroup C strains, StpC, and the tyrosine kinase-interacting protein, Tip Biesinger et al., 1995; Fickenscher et al., 1996) . Both genes, stpC and tip, are translated from one bicistronic mRNA, and are essential for the transforming activity (Fickenscher et al., 1996; Knappe et al., 1997; Duboise et al., 1998) . As a viral oncoprotein, StpC transforms rodent fibroblasts and causes tumors in transgenic mice. StpC specifically interacts with cellular Ras and tumor necrosis factor (TNF)-a receptorassociated factors inducing mitogen-activated protein kinase and NF-kB activation Murphy et al., 1994; Lee et al., 1999) . Tip was shown to bind, to be a substrate of, and to activate the tyrosine kinase Lck Wiese et al., 1996) . Furthermore, phosphorylated Tip was described to bind and activate signal transducer and activator of transcription (STAT) factors (Hartley and Cooper, 2000) . The oncogenic potential of Tip was demonstrated by lymphomagenesis in conditionally tip-transgenic mice (Wehner et al., 2001) . Moreover, Tip and StpC synergistically stimulate NF-kB activity and IL-2 gene expression (Merlo and Tsygankov, 2001 ). Regardless of the various interactions described for StpC and Tip in HVS-transformed T cells, the transformation process at the molecular level is poorly understood.
In the present study, we compared the gene expression profile of HVS-transformed and nontransformed human T cells. Using SSH and cDNA array hybridization, we were able to show that the chemokine ccl1/i-309 is one of the few cellular genes that are strongly upregulated in HVS-transformed T cells. CCL1 appears to engage in an autocrine loop via its specific CC-type chemokine receptor 8 (CCR8) on the transformed T cells and contributes to their activation and proliferation state and, thus, to their transformed phenotype.
Results

Only a minority of genes are deregulated in HVS-transformed T cells
To identify differentially expressed genes in human T cells after growth transformation with HVS, we first generated clonal pairs of transformed and nontransformed CD4 þ T cells. CD4 þ T cells were isolated from peripheral blood mononuclear cells with CD4-binding magnetic beads and cloned by limiting dilution and cultivation in the presence of irradiated feeder cells, IL-2, and mitogen (concanavalin A). All established clonal T-cell lines were CD4 þ as confirmed by flow cytometry. When sufficient cell numbers were available, part of the cells was infected with HVS C488.
When transformation of the infected cells was evident, mRNA from clonal pairs of HVS-transformed and nontransformed T cells was isolated. Prior to mRNA harvest, the cells had either been stimulated with phorbolester (tetradecanoyl phorbol acetate, TPA, 2 ng/ml) for 4 h or left untreated. The mRNA was used to generate 32 P-radiolabeled cDNA probes by reverse transcription in vitro. The cDNA probes were hybridized to identical pairs of commercially available gene array membranes carrying cDNA fragments of known human genes with various functions in cell biology (Atlas Human cDNA Expression Array, 588 genes, Clontech, Heidelberg, Germany) or coding for cytokines and receptors (Atlas Cytokine/Receptor Array, 268 genes, Clontech). Hybridization signals were visualized and quantified with a Fuji bioimager (Figure 1 ) and relative intensities (Figures 2 and 3) were calculated by normalizing signal intensities on membrane pairs for housekeeping genes such as ribosomal protein 9 and hypoxanthine-guanine phosphoribosyl-transferase (hprt), which show similar expression levels in transformed and nontransformed T cells. The ratio of the relative intensities for each hybridization signal on a pair of membranes indicated either the induction (Figure 2 ) or suppression factor (Figure 3 ) of a particular gene after transformation with HVS.
In accordance with maintained functional properties of T cells after transformation with HVS, this analysis indicated inconspicuous alterations of the gene expression profile for the majority of the genes tested. In agreement with the T H 1 or T H 0 cytokine expression profile of HVS-transformed T cells, we identified a number of induced cytokines related to this phenotype ( Figure 1 ). For instance, T H 1 cytokines such as IFN-g, TNF-a, and the chemokines MIP-1a, MIP-1b, and RANTES were found to be constitutively expressed in HVS-transformed T cells (Figure 2 , without TPA). Moreover, IL-2, IL-3, and granulocyte macrophage colony stimulating factor (GM-CSF) were also detectable after stimulation with TPA ( Figure 2 , with TPA), while T H 2 cytokines such as IL-5 and IL-13 were found to be downregulated in transformed T cells (Figure 3 ). In addition, we confirmed the known differential expression of the IL-2 receptor g-chain (IL-2Rg; Figure 2 ; Knappe et al., 1997) and of the tyrosine kinase Lyn (Figure 2 , top left panel, without TPA; Wiese et al., 1996) . Surprisingly, we found the genes for the receptor tyrosine kinase TrkB (Klein et al., 1989) and for the antiapoptotic chemokine CCL1, earlier designated as I-309 (Miller et al., 1989) , strongly induced in HVS-transformed T cells regardless of whether or not cells had previously been stimulated with phorbolester.
As a second method to identify genes that are overexpressed in T cells after herpesviral growth transformation, we applied SSH, a PCR-based technique, to amplify differentially transcribed mRNAs Only five genes of each hybridization experiment showed a rather strong downregulation. The T H 2 cytokines IL-5 and IL-13 were consistently among the strongest downregulated genes in all hybridization experiments (Hubank and Schatz, 1994; Diatchenko et al., 1996) . To maximize the efficiency of identifying upregulated cellular genes, we added, prior to subtraction, cloned viral cDNA to the driver cDNA population originating from the nontransformed T cells. This viral cDNA represented transcripts for stpC/tip and ie14/vsag, which are the main viral transcripts found in HVS-transformed T cells . Thus, subtraction of mRNA from HVS-transformed and nontransformed human T cells yielded cellular cDNA clones only. Many of these cDNA clones represented T-cell activation genes such as b 2 -microglobulin or the IL-2 receptor achain (IL2-Ra) ( Table 1 ). This correlates with earlier results describing various similarities between activated primary T lymphocytes and HVS-transformed T cells (Biesinger et al., 1992; Bro¨ker et al., 1993; Knappe et al., 1997; Fleckenstein, 2001, 2002) . Three separate experiments yielded libraries with comparable results. In agreement with our results from cDNA array hybridization, we identified the receptor tyrosine kinase trkB and the chemokine ccl1/i-309 as genes that are overexpressed in HVS-transformed T cells.
CCL1 is strongly induced in HVS-transformed T cells
Overexpression of ccl1 in HVS-transformed T-cell lines was confirmed by Northern blot hybridization ( Figure 4a ). Comparing ccl1 transcription in HVStransformed T cells with primary T lymphocytes that had been cultivated by repeated stimulation with irradiated feeder cells and mitogen (T blasts), we were able to detect high transcript levels for ccl1 only after stimulation with TPA. However, in contrast to primary T lymphocytes, transcription of ccl1 was strongly upregulated in HVS-transformed T-cell lines after stimulation with TPA. In addition, upon longer exposure, a faint ccl1 signal was observed in HVStransformed cells without additional stimulation, whereas this was not seen in nontransformed cells. Additionally, SSH provided evidence for two alternative splice variants of ccl1 in HVS-transformed T-cell lines ( Figure 4c ; Table 1 ). In addition to the known short ccl1 transcript of approximately 550 bp, we unambiguously showed the existence of the larger 2.4 kb transcript by Northern blot hybridization ( Figure 4a ). ccl1 consists of three exons, of which exon 3 is transcribed either in a short form with only 281 nucleotides (exon 3a) or in a long form with 2080 nucleotides (exon 3b) resulting in two types of transcripts for ccl1 with either 539 or 2338 nucleotides, respectively. Since this alternative splicing does not affect the protein size, the differential transcription might play a role in mRNA stability.
CCL1 is secreted from HVS-transformed T cells
To detect CCL1 expression in HVS-transformed T cells also at the protein level, we measured steady-state concentrations of CCL1 in the supernatants of a series of HVS-transformed T-cell lines. In contrast to primary nontransformed T-cell cultures, all HVS-transformed Tcell lines showed readily detectable levels of CCL1 in the culture supernatant within the range of 600-2800 pg/ml (Figure 5a ), even though high transcript levels for ccl1 were only detectable after phorbolester stimulation by Northern blot hybridization (Figure 4a ). When we measured the level of CCL1 secretion from nonstimulated clonal pairs of primary and HVS-transformed Tcell lines, CCL1 was only detectable in the supernatant from transformed T cells (Figure 5b ). While stimulation with IL-2 alone had no effect on CCL1 secretion, stimulation with IL-2 and TPA led to increased levels of CCL1 and also allowed detection of low levels of CCL1 in the supernatants of primary T-cell cultures. IL-2-and TPA-induced CCL1 secretion from transformed T cells was always considerably higher than from primary T cells. In contrast to HTLV1-transformed human T cells where only certain adult T-cell leukemia cells lines express CCL1 (Ruckes et al., 2001) , we detected CCL1 in the supernatants from all HVStransformed T-cell lines analysed. As a result, overexpression of CCL1 seems to be a common feature in HVS-transformed T-cell lines, which is even more evident at the protein level when compared with nontransformed parental T cells. 
HVS-transformed T cells express functional CCR8, the receptor for CCL1
To investigate whether CCL1 overexpression in HVStransformed T cells could give rise to an autocrine stimulation, we tested various HVS-transformed T-cell lines in an RNase protection assay for transcripts of CCtype chemokine receptor 8 (CCR8), the receptor for CCL1 (Figure 4b ). All tested HVS-transformed T-cell lines constitutively expressed CCR8. The human osteosarcoma-derived cell line Ghost/CCR8, which stably expresses CCR8, served as a positive control. The parental Ghost cell line, which is negative for CCR8, and the Burkitt's lymphoma line Raji were negative controls. Furthermore, by time-resolved flow cytometric detection of calcium mobilization after stimulation with recombinant CCL1, we were able to show that the HVStransformed T cells CB-15, CB-1810, CB-1811, CB-1812, A6/488, and B2/488 carry functional CCL1 receptors ( Figure 6 , and data not shown). Prior to stimulation, cells were loaded with the fluorophore Fluo-3. Calcium mobilization was measured over time (204 s) in the fluorescence 1 channel of the flow cytometer. Mouse monoclonal antibody OKT-3, which elicits calcium mobilization by triggering the CD3e-chain of the T-cell receptor complex, served as positive control. Independent experiments yielded comparable results. Thus, HVS-transformed human T-cell lines appear to express functional CCR8 on their surface, which can be triggered by CCL1.
CCL1 from the supernatant of HVS-transformed T cells protects murine T-cell lymphomas from dexamethasoneinduced apoptosis
Previously, CCL1 was shown to exhibit an antiapoptotic function conferring protection from dexamethasoneinduced apoptosis to the murine thymoma cell line BW5147 (Van Snick et al., 1996). We used this protein, was able to confer a maximal survival rate to dexamethasone-treated BW5147 cells (Figure 7a ). The antiapoptotic effect of CCL1 on dexamethasone-treated BW5147 cells could be reduced when neutralizing antibodies against CCL1 were added to the culture medium simultaneously (Figure 7b ). Neither the supernatant from HVS-transformed T-cell cultures nor recombinant CCL1 conferred survival to dexamethasone-treated BW5147 cells when G i protein-dependent signaling via CCR8, the receptor for CCL1, was blocked by pertussis toxin. Hence, CCL1 from the supernatant of HVS-transformed T-cell lines is biologically active.
CCL1 activates HVS-transformed T cells
To investigate the relevance of CCL1 secretion by HVStransformed T cells, we first measured the effect of neutralizing antibodies to CCL1 on the secretion levels of IFN-g and TNF-a into the supernatant of transformed T lymphocytes. Both IFN-g and TNF-a expressions are known to be upregulated in stimulated HVStransformed T cells (Figures 1 and 2 ; De Carli et al., 1993) . Neutralizing antibodies to CCL1 reduced secreted levels of IFN-g (Figure 8a ) in the culture supernatant of HVS-transformed T cells by at least 30%. Similarly, TNF-a production was reduced in three tested cell lines in the presence of antibodies against CCL-1 (Figure 8c ). Subsequent measurement of proliferation rates of HVS-transformed T cells in the presence of neutralizing antibodies to CCL1 revealed also a similar reduction in proliferation rates of up to 30% (Figure 8b ). Unspecific monoclonal mouse IgG had no effect on IFN-g and TNF-a secretion nor on cell proliferation, whereas pertussis toxin reduced secretion of IFN-g and TNF-a and proliferation rates of transformed T cells to even slightly lower levels. Thus, most of the pertussis toxin-blockable activity can be attributed to CCL1. These results indicate that HVStransformed T cells are activated by CCL1 and at least partially propagate by entertaining an autocrine loop that is mediated by the interaction of overexpressed CCL1 with the specific receptor CCR8 on transformed T cells.
Discussion
Although the growth transformation by HVS has been studied in detail, the mechanism by which HVS actually transforms T cells is not well understood (Fickenscher and Fleckenstein, 2001) . Our study compared the gene expression profile of HVS-transformed T lymphocytes with that of nontransformed parental T cells in order to identify cellular factors that might contribute to the transformation process. We observed that the gene expression profile of HVS-transformed T cells is strongly conserved in contrast to that of HTLV1-immortalized T-cell lines where it is dramatically altered and which cease to express the T-cell receptor and acquire independence from IL-2 (Inatsuki et , 1999) . We confirm that the gene expression profile of HVS-transformed T cells resembles that of activated T lymphocytes as previously described (Biesinger et al., 1992; Bro¨ker et al., 1993) . Moreover, we could also detect a cytokine shift toward a T H 0 or T H 1 phenotype (Bro¨ker et al., 1993; De Carli et al., 1993) . A novel finding was that HVS-transformed T cells, regardless of previous stimulation with TPA, constitutively upregulate the expression of the chemokine CCL1 (I-309) and that of the neurotrophin receptor TrkB. This was reproducibly detected with two different techniques, cDNA array hybridizations and SSH. We focused on the possible function of CCL1 expression in HVStransformed T cells with regard to autonomous growth. CCL1, initially named I-309 (inducible 309), and its murine homolog TCA-3 (T-cell activation gene 3) were originally identified as T-cell activation genes (Burd et al., 1987; Miller et al., 1989) . As a member of the CC subfamily of chemokines, CCL1 is characterized by an atypical additional pair of cysteines, which form a disulfide bridge that is relevant for its secretion as a glycosylated monomer of 15-16 kDa (Miller and Krangel, 1992; Paolini et al., 1994) . We showed that constitutive production of CCL1 is a common phenomenon in HVS-transformed T-cell lines and not an artifact of specific cell lines only, even though strong ccl1 transcription in HVS-transformed T cells was detectable only after phorbolester stimulation.
Similar to other chemokines, CCL1 was shown to cause chemotaxis for a number of cell types such as monocytes, natural killer cells, and T H 2 and regulatory T lymphocytes (Miller and Krangel, 1992; D'Ambrosio et al., 1998; Zingoni et al., 1998; Inngjerdingen et al., 2000; Colantonio et al., 2002) . Furthermore, antiapoptotic properties of CCL1 conferred protection from dexamethasone-induced apoptosis to the mouse thymoma line BW5147, and from CD95-mediated or dexamethasone-induced apoptosis to HTLV1-carrying adult T-cell leukemia lines (Van Snick et al., 1996; Ruckes et al., 2001) . Recently, the antiapoptotic activity of CCL-1 was linked to MAP kinase activation (Louahed et al., 2003; Spinetti et al., 2003) . We used its antiapoptotic activity to show that CCL1 from the supernatant of HVS-transformed T-cell cultures was biologically active. In contrast to other chemokines that often bind several different receptors, CCL1 appears to be specific for CCR8 (Goya et al., 1998) , a G i proteincoupled receptor with seven transmembrane helices that is expressed in thymus, spleen, and lymph nodes (Napolitano et al., 1996; Zaballos et al., 1996) . Expression of CCR8 could also be shown on lymphoid lines, such as Jurkat, Molt4, NK3.3, Hut78, and HTLV1-transformed T-cell lines such as JuanaW, and on T H 2 cells (Napolitano et al., 1996; Samson et al., 1996; D'Ambrosio et al., 1998; Zingoni et al., 1998; Ruckes et al., 2001) . In contrast to the heterogenous situation in Figure 6 Calcium ion mobilization by CCL1 in rhadinovirus-transformed T cells. Calcium mobilization was measured for 204 s in the HVS-transformed T-cell lines CB-15, CB-1810, CB-1811, and CB-1812. Cells loaded with Fluo-3 were stimulated after approximately 30 s with either 0.24 mg CCL1 (upper panels) or 2.0 mg murine monoclonal antibody OKT-3 (lower panels), which is directed against CD3e-chain of the T-cell receptor complex. The linear fluorescence intensity of Fluo-3 was measured over time in the FL1 channel Autocrine T-cell stimulation by CCL1 G Tamgüney et al HTLV1-transformed T cells, all analysed HVS-transformed T-cell lines expressed CCR8. Moreover, recombinant CCL1 was able to activate transformed cells, as determined by time-resolved measurement of calcium mobilization in six example cell lines (Figure 6 , and data not shown). CCL1-dependent calcium mobilization in T cells is still an uncommon observation; as yet, it has only been described for cutaneous regulatory T cells (Sebastiani et al., 2001) . The functionality of CCR8 and its overexpressed ligand CCL1 indicate a possible autocrine mechanism for their interaction in HVS-transformed T cells.
Due to earlier reports on antiapoptotic properties of CCL1, we first assumed that CCL1 could affect apoptosis in HVS-transformed T cells. However, when we analysed the influence of CCL1 on apoptosis and cell Neutralizing antibodies to CCL1 reduced the antiapoptotic effect of CCL1. The applied cell culture supernatant contained too high CCL1 concentrations showing that CCL1 antibodies were not inhibitory under these conditions. Pertussis toxin (P.T., 2.5 ng/ml) strongly reduced the antiapoptotic effect of B2/488 supernatants and inhibited G protein-dependent signal transduction via chemokine receptors such as CCR8, which is a specific receptor for CCL1. Mean values with standard deviations are shown for triplicate experiments survival in HVS-transformed T cells, we could not detect any specific effect (data not shown). This is in agreement with earlier results where growth transformation by HVS did not correlate with resistance to apoptosis (Kraft et al., 1998) .
Nonetheless, we were able to show that neutralizing antibodies to CCL1 not only reduced IFN-g and TNF-a secretion but also impeded overall cell proliferation of HVS-transformed T cells. In addition to the autocrine CD2/CD58 pathway inducing IL-2 and IL-3 (Mittru¨ck-er et al., 1992; Del Prete et al., 1994) , T-cell transformation by HVS seems to involve another autocrine loop where overexpressed CCL1 via CCR8 activates the cells and, thus, promotes cellular proliferation.
Interestingly, another g 2 -herpesvirus and a close relative to HVS, human herpesvirus type 8 (HHV-8), the etiological agent for Kaposi's sarcoma, itself encodes two viral CC chemokines, vMIP-I and vMIP-II, that bind to CCR8. While vMIP-I is a specific agonist for CCR8, vMIP-II seems to bind as a promiscuous antagonist to CCR8 and other chemokine receptors (Dairaghi et al., 1999) . The Molluscum contagiosum poxvirus-encoded cMCC-I, in contrast, is a specific antagonist of CCR8 (Lu¨ttichau et al., 2000) . Although it remains still unclear which selective advantage is conferred by these virally encoded chemokines, it is obvious that CCR8 engagement seems to be important in various transforming virus systems.
Materials and methods
Cells and cell culture
Mononuclear cells were isolated from human blood by Ficoll density gradient centrifugation. CD4 þ T cells were purified using anti-CD4 antibody-coated magnetic beads (Dynal, Oslo, Norway) . Clonal CD4 þ T cells were established by limiting dilution and T-cell stimulation in the presence of concanavalin A (4 mg/ml) and irradiated feeder cells. To obtain clonal pairs of HVS-transformed and nontransformed human T cells, 5 Â 10 6 cells of the established CD4 þ T-cell clones were infected with the infectious supernatant from lytically infected Owl-monkey kidney cells (approximately 10 6 PFU/ml). T-cell cultures and transformation experiments were carried out according to published protocols (Fickenscher and Fleckenstein, 2002) . A6, B2, B5, and A6/488, B2/488, B5/488 are newly established clonal pairs of nontransformed and HVS-transformed human CD4 þ T-cell lines. CB-15, 3C, CB-1810, CB-1811, and CB-1812 are HVS-transformed human T-cell lines generated as described previously (Biesinger et al., 1992; Fickenscher et al., 1996; Fickenscher and Fleckenstein, 2002) . The human osteosarcoma-derived cell line Ghost and the CCR8-expressing stable transfectant Ghost/CCR8 were grown in Dulbecco's medium supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 50 mg/ml gentamycin, 500 mg/ ml G418, and 100 mg/ml hygromycin. To Ghost/CCR8 cells, 1 mg/ml puromycin was added. The Burkitt's lymphoma line Raji was grown in RPMI 1640 with 10% FBS, 2 mM Lglutamine, 1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 10 mM HEPES, 50 mg/ml gentamycin, and 1 mM Na pyruvate. The murine thymic lymphoma line BW5147 was cultured in Iscove's medium supplemented with 10% FBS, 1.5 mM Lglutamine, 0.24 mM L-asparagine, 0.55 mM L-arginine, 50 mg/ml gentamycin, and 50 mM b-mercaptoethanol (Sigma, Taufkirchen, Germany).
Measurement of intracellular Ca 2 þ mobilization
Cells (5 Â 10 6 /ml, lines A6/488, B2/488, CB-15, CB-1810, CB-1811 and CB-1812) were washed and loaded with a 1 : 1 mixture of 8 mM fluo-3-acetoxy-methylester and 1 mM pluronic F-127 (Molecular Probes, Leiden, The Netherlands) in complete RPMI with 10% FBS. After 60 min at 371C with gentle agitation, cells were washed again. Calcium mobilization was measured over time for 204 s after stimulation with either recombinant CCL1 (0.48 mg/ml; Van Snick et al., 1996) or the mouse anti-CD3 monoclonal antibody OKT-3 (4.0 mg/ ml; Janssen-Cilag, Neuss, Germany). Analysis was performed on a FACS calibur flow cytometer (Becton Dickinson, Heidelberg, Germany) while cells and reagents were maintained at 371C.
Cytokine measurements
Secreted IFN-g and TNF-a were measured from the cell-free supernatants by sandwich ELISA with OptEIAt antibody sets (Pharmingen, Heidelberg, Germany) following the manufacturer's instructions. Briefly, 96-well plates were coated with capture antibody overnight at 41C. The plates were washed with phosphate-buffered saline (PBS) with 0.05% Tween 20 and blocked with 10% bovine serum albumin in PBS with 0.05% Tween 20 for 1 h at room temperature. The plates were then incubated with diluted culture supernatants for 2 h at room temperature, washed and incubated with peroxidaseconjugated detection antibody. The plates were washed and developed with 3 0 3 0 5 0 5 0 -tetramethylbenzidine solution (Sigma). The optical density was read on a microplate reader at 450 nm. CCL1 was determined using the mouse monoclonal antibody 35305.11 for coating and the polyclonal biotinylated goat antibody BAF272 for detection (R&D Systems, Wiesbaden, Germany) together with streptavidin-conjugated horseradish peroxidase (Zymed Laboratories, San Francisco, CA, USA).
Proliferation assays
The antiapoptotic activity of cell culture supernatants was measured using BW5147 cells, which undergo apoptosis after treatment with dexamethasone (Van Snick et al., 1996) . BW5147 cells (2-3 Â 10 4 ) were cultured in triplicate in microtiter plates in a final volume of 200 ml. Apoptosis in BW5147 cells was induced with 0.25 mM dexamethasone (Sigma). To test the specificity of the antiapoptotic activity in the supernatants, sodium azide-free anti-CCL1 antibody (R&D) was added. When measuring proliferation in HVStransformed T cells, isotypic monoclonal IgG1 (R&D) was used as a nonspecific control. G protein-dependent CCL1 receptor signaling was blocked with 2.5 ng/ml pertussis toxin (Biomol, Hamburg, Germany). After 48 h, cells were pulsed for 16 h with 0.2 mCi [ 3 H]thymidine (Amersham Biosciences, Freiburg, Germany). Finally, cells were harvested on glass fiber filters (Packard/Perkin Elmer, Rodgau, Germany) and the bound radioactivity was quantified by BAS 2000 bioimaging (Fuji, Tokyo, Japan).
Gene array analyses
Total RNA was prepared from clonal pairs of nontransformed and HVS-transformed human peripheral T cells that had either been stimulated with TPA (4 mg/ml) for 6 h or left untreated prior to RNA harvest. Poly(A)
þ RNA was isolated from total RNA using oligo(dT)-Dynabeads (Dynal). Poly(A) þ RNA samples were reverse transcribed in the presence of [a 32 P]dATP, and the radiolabeled cDNA probes were hybridized to sets of two identical membranes, carrying various cDNAs for known human genes (Atlas Human cDNA Expression Array, Atlas Human Cytokine/Receptor Array; Clontech, Heidelberg, Germany). After hybridization and extensive washes, the membranes were subjected to bioimaging (Fuji) and hybridization spot intensities were quantified electronically.
Suppressive subtractive hybridization
Using the acidic phenol extraction method, total RNA was prepared from nontransformed and HVS-transformed human T cells. cDNA was generated from purified polyadenylated mRNA with avian myeloblastosis virus reverse transcriptase (Clontech). The second strand was synthesized by a mixture of DNA polymerase I, RNase H, Escherichia coli DNA ligase, and T4 DNA polymerase. Plasmid DNA fragments (200 ng) of the viral genes stpC, tip, and ie14/svag were added to the cDNA from the nontransformed T cells in order to eliminate them from the enriched fraction of differentially expressed genes. Double-stranded cDNA was digested with RsaI to create small fragments. Specific adapters were ligated to the cDNA fragments from the HVS-transformed T cells in order to allow subtraction of cDNA from nontransformed T cells (PCR Select, Clontech). Advantage KlenTaq polymerase (Clontech) was applied for PCR. Subtracted PCR products were cloned into pCRII (Invitrogen, Karlsruhe, Germany) and sequenced using M13 reverse and T7 primers with the dyedideoxy terminator method (Applied Biosystems, Weiterstadt, Germany).
RNase protection assays
Chemokine receptor mRNA levels were analysed by RNase protection using the RiboQuant Multiprobe RNase protection assay system together with the hCR-5 RiboQuant Multiprobe template set (Pharmingen), following the supplier's instructions. In brief, total RNA obtained from 4 Â 10 6 cells (4-6 mg RNA) was hybridized to the [a 32 P]dATP-labeled RNA probe, which had been previously synthesized from the multiprobe template set. Single-stranded RNA and free probe were digested by RNases A and T1. After a proteinase K (Sigma) digestion, protected RNA was phenol purified, precipitated, and analysed on a 6% denaturing polyacrylamide gel. The protected RNAs were visualized by bioimaging (Fuji).
Northern blot analysis
Total RNA was prepared by the acidic guanidine-thiocyanate method. Samples (10 mg/lane) were separated by denaturing 1% formaldehyde agarose gels and were then blotted onto nylon membranes. The membranes were hybridized with the indicated [a 32 P]dATP-radiolabeled cDNA probe, followed by bioimaging (Fuji).
